INCBB099280

· Abramson Cancer Center at Penn Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCBB099280, covering 2024-08-09 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC) [Phase 1]